Covid -19 has changed the data privacy paradigm. What used to be controversial with regards to accessing and mining large data sets with Business Associate Agreements (BAA), due to ensuing consumer privacy backlash is beginning to become more acceptable. While we are still at baby
The JP Morgan Health Conference was a great week in regards to meetings in the digital health and biotech ecosystem. As mentioned in Modern Healthcare, it’s the week where one can make enough contacts to hold over for a year! Well, that’s a bit of
We learned not long ago that Google is acquiring Fitbit. It’s easy to see why. Data and users may sound like the main consideration for this deal, but there is more at play. Hardware meets software Over the last several years, Google has shown its
Much is talked about health care distribution channels such as payers here in the US. Yet just across the atlantic, there is a payer that is just as important especially when it comes to testing new AI ideas – the UK National Health Service (NHS).
Data interoperability is the flavor of the month. Everyone is working on it. Different EHR providers mean ‘proprietary data’ and impact to revenue hence naturally system A can’t talk to system B when patient changes health plan, provider or employer benefits Apple may be bringing
Considering the launch of a Bayer campaign back in 2016 reported by Fierce Pharma, Facebook has been building teams that sell pharma ads to the health care sector. While still in the early stages, it is no secret that Google built those teams years ago